Angana Biswas

474 total citations
14 papers, 255 citations indexed

About

Angana Biswas is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Angana Biswas has authored 14 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Angana Biswas's work include Protein Degradation and Inhibitors (3 papers), Autophagy in Disease and Therapy (3 papers) and Heat shock proteins research (3 papers). Angana Biswas is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Autophagy in Disease and Therapy (3 papers) and Heat shock proteins research (3 papers). Angana Biswas collaborates with scholars based in India and United States. Angana Biswas's co-authors include Mahitosh Mandal, Y. Rajesh, Subhayan Das, Indranil Banerjee, Pralay Mitra, Pritam Roy, Paul B. Fisher, Luni Emdad, Ipsita Pal and Swadesh K. Das and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Biochemical Pharmacology.

In The Last Decade

Angana Biswas

14 papers receiving 253 citations

Peers

Angana Biswas
Jaewan Jeon South Korea
Alison Howarth United Kingdom
Mila Sajinovic Australia
Mayuri Prasad United States
Xiaotian Qi China
Xiaojia Huang China
Leonardo Carmo de Andrade-Lima Brazil
Ji Shi China
Nhat D. Quach United States
Jessica L. Weatherbee United States
Jaewan Jeon South Korea
Angana Biswas
Citations per year, relative to Angana Biswas Angana Biswas (= 1×) peers Jaewan Jeon

Countries citing papers authored by Angana Biswas

Since Specialization
Citations

This map shows the geographic impact of Angana Biswas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angana Biswas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angana Biswas more than expected).

Fields of papers citing papers by Angana Biswas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angana Biswas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angana Biswas. The network helps show where Angana Biswas may publish in the future.

Co-authorship network of co-authors of Angana Biswas

This figure shows the co-authorship network connecting the top 25 collaborators of Angana Biswas. A scholar is included among the top collaborators of Angana Biswas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angana Biswas. Angana Biswas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Roy, Pritam, Chandan Kanta Das, Abhijit Das, et al.. (2025). PSMC2 promotes resistance against temozolomide in glioblastoma via suppressing JNK-mediated autophagic cell death. Biochemical Pharmacology. 233. 116755–116755. 3 indexed citations
2.
Jena, Bikash Chandra, Chandan Kanta Das, Indranil Banerjee, et al.. (2022). TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation. Experimental Cell Research. 417(1). 113195–113195. 36 indexed citations
3.
Biswas, Angana, Y. Rajesh, Subhayan Das, et al.. (2022). Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma. Cancer Letters. 544. 215811–215811. 8 indexed citations
4.
Roy, Pritam, et al.. (2022). An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(3). 188734–188734. 13 indexed citations
5.
6.
Jena, Bikash Chandra, Chandan Kanta Das, Indranil Banerjee, et al.. (2022). TGF-β1 Induced Autophagy in Cancer Associated Fibroblasts During Hypoxia Contributes EMT and Glycolysis Via MCT4 Upregulation. SSRN Electronic Journal. 1 indexed citations
7.
Biswas, Angana, Y. Rajesh, Pralay Mitra, & Mahitosh Mandal. (2020). ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(1). 188389–188389. 17 indexed citations
8.
Rajesh, Y., Angana Biswas, Payel Banik, et al.. (2020). Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma. Oncotarget. 11(13). 1097–1108. 16 indexed citations
9.
Rajesh, Y., Angana Biswas, Indranil Banerjee, et al.. (2020). Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma. Proceedings of the National Academy of Sciences. 117(22). 12324–12331. 38 indexed citations
10.
Rajesh, Y., Anupam Banerjee, Ipsita Pal, et al.. (2019). Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(7). 1196–1209. 32 indexed citations
11.
Rajesh, Y., Angana Biswas, Subhayan Das, et al.. (2019). Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma. Biochemical Pharmacology. 164. 1–16. 29 indexed citations
12.
13.
Rajesh, Y., Angana Biswas, & Mahitosh Mandal. (2017). Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition. Experimental Cell Research. 359(2). 299–311. 39 indexed citations
14.
Rajesh, Y., Angana Biswas, Subhayan Das, & Mahitosh Mandal. (2017). Abstract 4105: Diosgenin and temozolamide: A potential combinatorial chemotherapy to overcome temozolamide resistance in glioblastoma multiforme. Cancer Research. 77(13_Supplement). 4105–4105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaewan Jeon Breakdown of academic impact, for papers by Alison Howarth Breakdown of academic impact, for papers by Mila Sajinovic Breakdown of academic impact, for papers by Mayuri Prasad Breakdown of academic impact, for papers by Xiaotian Qi Breakdown of academic impact, for papers by Xiaojia Huang Breakdown of academic impact, for papers by Leonardo Carmo de Andrade-Lima Breakdown of academic impact, for papers by Ji Shi Breakdown of academic impact, for papers by Nhat D. Quach Breakdown of academic impact, for papers by Jessica L. Weatherbee
Rankless by CCL
2026